We are live on ! Find out more
TM

Triatomic Management Portfolio holdings

AUM $3.39M
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
-3.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$97.6M
AUM Growth
-$51M
Cap. Flow
-$53.7M
Cap. Flow %
-55.01%
Top 10 Hldgs %
67.4%
Holding
77
New
22
Increased
15
Reduced
9
Closed
25

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.78M
2
BEKE icon
KE Holdings
BEKE
+$980K
3
SNOW icon
Snowflake
SNOW
+$800K
4
BABA icon
Alibaba
BABA
+$788K
5
GOTU icon
Gaotu Techedu
GOTU
+$738K

Top Sells

Rank Stock Value
1
IOT icon
Samsara
IOT
+$1.68M
2
CAR icon
Avis
CAR
+$1.46M
3
DDOG icon
Datadog
DDOG
+$1.1M
4
LMND icon
Lemonade
LMND
+$1.01M
5
WSM icon
Williams-Sonoma
WSM
+$973K

Sector Composition

Rank Sector Weight
1 Healthcare 12.71%
2 Technology 7.19%
3 Consumer Discretionary 4.71%
4 Real Estate 3.24%
5 Communication Services 2.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
26
Guardant Health
GH
$21.3B
$716K 0.73%
20,000
-15,072
-43% -$433K
GOTU icon
27
Gaotu Techedu
GOTU
$458M
$676K 0.69%
+234,000
New +$738K
LYFT icon
28
Lyft
LYFT
$6.22B
$668K 0.68%
69,674
-6,000
-8% -$57.7K
MRNA icon
29
Moderna
MRNA
$22B
$638K 0.65%
5,250
+850
+19% +$113K
DADA
30
DELISTED
Dada Nexus
DADA
$614K 0.63%
+115,608
New +$700K
BNTX icon
31
BioNTech
BNTX
$23.3B
$608K 0.62%
5,636
BZ icon
32
Kanzhun
BZ
$7.36B
$602K 0.62%
+40,000
New +$669K
TOI icon
33
The Oncology Institute
TOI
$513M
$498K 0.51%
904,689
+94,544
+12% +$50K
MSFT icon
34
Microsoft
MSFT
$3.62T
$491K 0.5%
+1,443
New +$452K
TOST icon
35
Toast
TOST
$19B
$456K 0.47%
20,225
-20,510
-50% -$409K
NVDA icon
36
NVIDIA
NVDA
$5.01T
$444K 0.45%
10,500
-19,500
-65% -$647K
CPNG icon
37
Coupang
CPNG
$29.5B
$424K 0.43%
+24,340
New +$397K
ZLAB icon
38
Zai Lab
ZLAB
$2.05B
$360K 0.37%
+13,000
New +$425K
ELV icon
39
Elevance Health
ELV
$83B
$311K 0.32%
+700
New +$323K
TDOC icon
40
Teladoc Health
TDOC
$1.21B
$304K 0.31%
+12,001
New +$302K
ACMR icon
41
ACM Research
ACMR
$5.43B
$282K 0.29%
+21,581
New +$227K
UNH icon
42
UnitedHealth
UNH
$377B
$276K 0.28%
575
+365
+174% +$178K
TSM icon
43
TSMC
TSM
$2.11T
$227K 0.23%
2,245
-255
-10% -$23.7K
AEHR icon
44
Aehr Test Systems
AEHR
$2.99B
$207K 0.21%
5,010
-15,875
-76% -$521K
SNTI icon
45
Senti Biosciences Holdings
SNTI
$11.5M
$188K 0.19%
30,053
+8,965
+43% +$87.5K
NNOX icon
46
Nano X Imaging
NNOX
$76.6M
$186K 0.19%
12,000
OMIC
47
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$162K 0.17%
6,491
+917
+16% +$26.9K
CANO
48
CALL
DELISTED
Cano Health, Inc.
CANO
$110K 0.11%
+794
New +$102K
IVVD icon
49
Invivyd
IVVD
$163M
$27.1K 0.03%
25,800
NEGG icon
50
Newegg Commerce
NEGG
$283M
$25.7K 0.03%
1,100

Similar funds

Triatomic Management's Q2 2023 Portfolio in Review

As of Q2 2023, Triatomic Management held 77 positions worth $97.6M, down 34% from $149M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Triatomic Management withdrew a net $53.7M in Q2 2023, closing 25 positions and reducing 9 holdings. Its most notable exit was Avis, an estimated $1.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Triatomic Management opened a new position in Snowflake worth $866K.

  • Triatomic Management's largest Q2 2023 buy was Snowflake: 4,920 shares worth $866K.
  • Triatomic Management added most to Advanced Micro Devices in Q2 2023, an estimated $1.78M increase.
  • Triatomic Management's biggest Q2 2023 reduction was Samsara, cutting an estimated $1.68M.
  • Triatomic Management fully exited Avis in Q2 2023, selling an estimated $1.46M.
  • Triatomic Management's ten largest holdings make up 67% of its $97.6M portfolio in Q2 2023.
  • Triatomic Management opened 22 new positions and closed 25 in Q2 2023.
  • Triatomic Management's portfolio value fell 34% quarter-over-quarter to $97.6M.

Based on Triatomic Management's 13F filing for Q2 2023, filed 14 Aug 2023.